CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE - Generic Drug Details

What are the generic drug sources for calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate and what is the scope of freedom to operate?

Calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate is the generic ingredient in twelve branded drugs marketed by B Braun, Fresenius Kabi Usa, Otsuka Icu Medcl, Miles, and Baxter Hlthcare, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

Five suppliers are listed for this compound.

Summary for CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

US Patents:	0
Tradenames:	12
Applicants:	5
NDAs:	9
Finished Product Suppliers / Packagers:	5
Clinical Trials:	89
DailyMed Link:	CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE at DailyMed

Recent Clinical Trials for CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of California, Los Angeles	PHASE2
University of Pittsburgh	PHASE4
Fundacin Cardioinfantil Instituto de Cardiologa	PHASE4

See all CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE clinical trials

Pharmacology for CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Drug Class	Blood Coagulation Factor Osmotic Laxative Phosphate Binder Potassium Salt
Mechanism of Action	Acidifying Activity Osmotic Activity Phosphate Chelating Activity
Physiological Effect	Increased Coagulation Factor Activity Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Anatomical Therapeutic Chemical (ATC) Classes for CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

A12AA	Calcium
A12A	CALCIUM
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12BA	Potassium
A12B	POTASSIUM
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05CB	Salt solutions
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

G04BA	Acidifiers
G04B	UROLOGICALS
G04	UROLOGICALS
G	Genito-urinary system and sex hormones

US Patents and Regulatory Information for CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Otsuka Icu Medcl	POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	019685-003	Oct 17, 1988		DISCN	Yes	No
Fresenius Kabi Usa	POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	211428-001	Nov 9, 2021		DISCN	No	No
Baxter Hlthcare	LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	016679-001	Approved Prior to Jan 1, 1982	AP	RX	No	No

CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE Market Analysis and Financial Projection

Last updated: February 17, 2026

Market Dynamics and Financial Trajectory for Chloride, Dextrose, and Sodium Solutions

Analyses focus on calcium chloride, dextrose, potassium chloride, sodium chloride, and sodium lactate. These products, essential in medical, industrial, and food sectors, collectively exhibit steady demand growth driven by healthcare needs, industrial applications, and geopolitical factors.

Market Overview

Collectively, the global market for these solutions is valued at approximately $3.2 billion in 2022, with an expected compound annual growth rate (CAGR) of 5% over the next five years. This growth aligns with expanding healthcare infrastructures, increased surgical procedures, and food industry modernization.

Key segments:

• Healthcare (intravenous therapy, electrolyte replenishment)
• Industrial (water treatment, chemical manufacturing)
• Food processing (preservation, flavor enhancement)

Supply Chain and Production Trends

Mature manufacturing bases in North America, Europe, and Asia-Pacific dominate. China leads in raw material synthesis, especially for sodium chloride and potassium compounds. Raw material prices, geopolitical tensions, and environmental regulations influence supply stability and cost structures.

Pricing Trends and Revenue Drivers

Pricing remains relatively stable but susceptible to raw material costs and regulatory shifts. Dextrose has seen a 3-4% annual price increase, driven by energy costs and fermentation process advancements. Sodium chloride prices have plateaued post-2020, whereas potassium chloride levels fluctuate with agricultural demand.

Competitive Landscape

Leading companies include Baxter International, B. Braun Melsungen, and Hospira. These firms focus on R&D for enhanced formulations, aiming for improved bioavailability and stability. Mergers and acquisitions have consolidated market share, especially in IV solutions.

Regulatory Environment

Stringent regulations for pharmaceutical-grade compounds, especially in the U.S. (FDA), Europe (EMA), and China (NMPA), impact R&D timelines and costs. Recent bans on certain production processes due to environmental concerns have increased compliance costs.

Financial Trajectory Projections (2023-2028)

Year	Market Value (USD Billion)	Growth Rate (%)	Key Drivers
2023	3.4	6.3	Post-pandemic healthcare rebound, supply chain stabilization
2024	3.6	5.9	Continued medical consumption, industrial recovery
2025	3.8	5.6	New regulations, volume growth in emerging markets
2026	4.0	5.3	Technological innovations, reduced manufacturing costs
2027	4.2	5.0	Growing incorporation in food preservation
2028	4.4	4.8	Market saturation plateau, price stabilization

Market Challenges

Demand uncertainty exists due to potential shifts in healthcare protocols and food industry regulations. Raw material price volatility and environmental policies could increase production costs. Competition from alternative electrolytes and substitutes, especially for medical purposes, could restrict growth.

Investment Opportunities

• Development of biodegradable packaging solutions for bulk supplies.
• R&D for formulations with increased stability or targeted delivery.
• Entry into emerging markets with expanding healthcare infrastructure.

---

Key Takeaways

• The global market for chloride, dextrose, and sodium solutions is projected to grow approximately 5% annually through 2028.
• Demand driven primarily by medical applications, with industrial and food sectors contributing.
• Supply chain risks center on raw material availability, geopolitical factors, and environmental regulations.
• Leading firms focus on R&D and regulatory compliance to maintain competitiveness.
• Pricing remains relatively stable but sensitive to input costs and regulatory mandates.

---

FAQs

1. What factors most influence prices for these products? Raw material costs, production regulations, energy prices, and geopolitical stability.

2. Which applications drive most demand? Intravenous electrolyte therapy in healthcare accounts for the largest share, followed by industrial uses like water treatment.

3. How do regulatory changes impact this market? Stricter quality standards and environmental policies increase compliance costs and can disrupt supply chains.

4. Are alternative products gaining market share? Yes, especially in medical applications, where substitutes such as magnesium and phosphate solutions are explored.

5. What regions hold the most growth potential? Asia-Pacific and Latin America due to expanding healthcare infrastructure and industrialization.

---

References

[1] MarketsandMarkets, "Electrolyte Solutions Market," 2022.
[2] Allied Market Research, "Global Intravenous Solutions Market," 2022.
[3] U.S. Food and Drug Administration (FDA), Regulatory Updates, 2023.